Rajesh Balkrishnan

ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 9

Top Venues

Aging medicine (Milton (N.S.W))

Cancer reports (Hoboken, N.J.)

Health equity

Substance abuse

University of Virginia

University of North Carolina at Chapel Hill (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Virginia Apr 25 2015

United States

Professor :: Public Health Sciences

Education History

University of North Carolina at Chapel Hill Sep 01 1995 - Jun 30 1999

United States

PHD :: Health Policy

Publications

Akhil Rekulapelli, Raj P Desai, Aditya Narayan, Linda W Martin, Richard Hall, James M Larner, Rajesh Balkrishnan
Racial and Treatment Center Differences on Time to Treatment Initiation for Nonsmall Cell Lung Cancer Patients Receiving Radiation Therapy As an Initial Treatment. Health equity 6 (1) (2022)
Jakob D Jensen, Jackilen Shannon, Ronaldo Iachan, Yangyang Deng, Sunny Jung Kim, Wendy Demark-Wahnefried, Babalola Faseru, Electra D Paskett, Jinxiang Hu, Robin C Vanderpool, DeAnn Lazovich, Jason A Mendoza, Sanjay Shete, Linda B Robertson, Rajesh Balkrishnan, Katherine J Briant, Benjamin Haaland, David A Haggstrom, Bernard F Fuemmeler, null null
Examining Rural-Urban Differences in Fatalism and Information Overload: Data from 12 NCI-Designated Cancer Centers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (2) (2022)
Sara Kakatkar, Aditya Narayan, Rajesh Balkrishnan
Prescription analgesic overuse in older adults: Can we mitigate this growing problem? Aging medicine (Milton (N.S.W)) 5 (4) (2022)
Sara Kakatkar, Aditya Narayan, Rajesh Balkrishnan
Prescription analgesic overuse in older adults: Can we mitigate this growing problem? Aging medicine (Milton (N.S.W)) 5 (4) (2022)
Akhil Rekulapelli, Lucas E Flausino, Gayatri Iyer, Rajesh Balkrishnan
Effectiveness of immunological agents in non-small cell lung cancer. Cancer reports (Hoboken, N.J.) (2022)
Rajesh Balkrishnan, Raj P Desai, Aditya Narayan, Fabian T Camacho, Lucas E Flausino, Roger Chammas
Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: A Medicare SEER cohort analysis. Cancer medicine 10 (15) (2021)
Aditya Narayan, Rajesh Balkrishnan
A health crisis within a health crisis: Opioid access in the COVID-19 pandemic. Substance abuse 42 (2) (2021)
Delaney D Ding, Rajesh Balkrishnan, Vakaramoko Diaby
In our war against the opioid epidemic, could 'weed' be a winner? Expert review of pharmacoeconomics & outcomes research 20 (5) (2020)
Xi Tan, Tareq Fabian Camacho, Virginia T LeBaron, Leslie J Blackhall, Rajesh Balkrishnan
Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens. Breast cancer research and treatment 165 (2) (2017)

Rajesh Balkrishnan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rajesh Balkrishnan